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 Vernal keratoconjunctivitis (VKC) is a severe chronic in-
flammatory disease of the conjunctiva. The disease is charac-
terized by an allergic phenotype with infiltration of lympho-
cytes (mostly Th2), eosinophils, and mast cells [1]. In VKC,
Th2 inflammation is associated with marked tissue remodel-
ing as shown by fibroblast (FBs) activation, epithelial growth,
subepithelial fibrosis, and extracellular matrix (ECM) depo-
sition, resulting in giant papillae formation [2]. ECM analysis
has shown a substantial increase in total collagen (procollagen
and types I, III, and IV collagen), with an altered collagen
ratio, both in tears and conjunctiva [3].Increased ECM is re-
ferred to increased expression of cytokines and growth fac-
tors, from either Th2-type and other inflammatory cells, which
are known to stimulate resident/activated FBs to overproduce
ECM [4]. Overt production and deposition of ECM eventu-
ally results from an unbalance between collagen production
and Matrix Metalloproteinases (MMP1, MMP2 and MMP9)
activities [1,3].
A variety of inflammatory- and stromal-derived cytokines,
such as TNF-α, IL-1, IL-4, IL-13, and IL-6, and growth fac-
tors, such as transforming growth factor β1 (TGFβ1) have been
reported to cause chronic inflammation, structural changes,
tissue remodeling, as well as fibrosis [5,6]. All these factors
are increased in the peripheral blood, tears, and conjunctiva
of patients with VKC [2].
To date, TGFβ1 represents the main profibrogenic factor
responsible for the imbalance in ECM metabolism as well as
for the chemoattraction and survival of FBs and myoFBs. In-
terestingly, nerve growth factor (NGF) has been recently pros-
pected as another factor playing a role in stromal-epithelial
interaction during wound-healing and tissue repair processes
[7,8]. Certainly, NGF is significantly increased in both serum
and conjunctiva of patients with VKC [9].
We previously reported a profibrogenic NGF effect on in
vitro primary cultures of healthy conjunctival FBs (healthy-
FBs) [8]. Since nothing is known about the possible role of
NGF (increased in VKC-affected conjunctiva) on primary
cultures of VKC conjunctival FBs (VKC-FBs), we exposed
these cells to increasing NGF concentrations. In addition, some
in vitro parameters of tissue remodeling were evaluated.
METHODS
Reagents:  Unless otherwise noted, sterile tissue culture plas-
tic-ware and analytical grade reagents were from NUNC
(Roskilde, Denmark), SERVA (Weidelberg, Germany), ICN
(Costa Mesa, CA), Euroclone (Milan, Italy), and Invitrogen-
Gibco (Paisley, UK).
Cell culture and experimental procedure:  FBs were iso-
lated from the upper tarsal VKC (n=3; 3M, range 11-15, mean
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981age 12.67±2.08) and sex/age matched healthy (n=3) conjunc-
tiva. Informed consent was given by the parents of each pa-
tient and the approval of the Intramural Ethic Committee was
granted, in conformity to the Declaration of Helsinki. The di-
agnosis of active VKC was based on history, clinical exami-
nation and the presence of eosinophils in conjunctival biopsy.
Clinical scores (0-3: 0, absent; 1, weak; 2, mild; 3, severe) for
each ocular symptom (itching, tearing, photophobia and for-
eign body sensation) and each sign (conjunctival hyperemia,
mucous discharge, papillae and corneal epithelial erosion) were
assigned at the time of examination. Total symptom (range 0-
3) and sign scores (0-12) were calculated showing: total symp-
tom score of 7.33±4.51 and total sign score of 8.67±3.05. The
three patients showing lid-ptosis were submitted to surgical
removal of the papillae that were processed in this study.
Biopsies were put as explants in 24-well plates and left to
attach for 10 min, before adding medium (DMEM) supple-
mented with 10% heat-inactivated Fetal Bovine Serum (FBS),
2 mM glutamine, 100 U/ml penicillin and 100 µg/ml strepto-
mycin. Cells outgrowing from biopsies (37 °C, 5% CO2 in air,
by 1 week), were quickly trypsinized (0.2% trypsin/0.025%
EDTA), assessed for the absence of epithelial cell contami-
nants (cytokeratin 19, 1:100; Dako Corp., Carpinteria, CA)
and screened as mycoplasm free cultures (otherwise treated
for 1 generation with 5 µg/ml Mycoplasm Removal Agent;
ICN). FBs were sub-cultured (T-21/T-75 cm2 flasks) and used
for the experiments (3rd to 4th passage) after 3 h of serum
starvation (synchronization and reduction of
autophosphorylation) [10].
For the specific experiments, confluent FBs were treated
with increasing NGF concentrations (murine βNGF; 1-500 ng/
ml; produced according to a standardized protocol [11]) in
minimal DMEM (0.5% FBS) [8]. Biochemical and molecular
evaluations were performed 2 days after stimulation. For block-
ing experiments, serum-starved FBs were preincubated for 1
h with 500 ng/ml αNGF (R&D Systems, Minneapolis, MN)
or with 100 ng/ml αtrkANGFR (Calbiochem, La Jolla, CA) or
100 ng/ml αp75NTR (Calbiochem) specific neutralizing anti-
bodies, before the addition of NGF alone (untreated FBs) or
in the same blocking reagents (pretreated FBs), for two days.
Whenever required and according to literature [6,12], human
TGFβ1 (1-10 ng/ml, R&D) was used as positive control in
some experiments.
Confocal microscopy:  Confluent monolayers (on steril-
ized round glasses, EMS, Hatfield, PA) were washed in Hank’s
Balanced Sodium Salt (HBSS), fixed in 2% ρ-formaldehyde
(PFA) - 0.1 M Phosphate Buffer (PB), rinsed in 10 mM PB -
137 mM NaCl (phosphate buffered saline, PBS), quenched in
50 mM NH4Cl-PBS, permeabilized in 0.5% Triton X-100 PBS
(TX-PBS) and finally blocked in 0.8% bovine serum albumin
(BSA)-PBS. Monolayers were then probed with the follow-
ing antibodies in 0.05% Tween20-PBS (TW-PBS): rabbit anti-
human trkANGFR antibody (2 µg/ml; Santa Cruz Biotech, Santa
Cruz, CA); goat anti-human p75NTR antibody (2 µg/ml; Santa
Cruz) and mouse anti-human αSMA antibodies (1/50;
Novocastra, Milan, Italy). Specific binding of the primary
antibody was detected using Cy2 or Cy3 conjugated F(ab)2
antibodies in TW-PBS (Jackson Laboratories, West Grove,
PA). Control immune-staining was performed by substituting
primary antibodies with control irrelevant IgG (Vector Labo-
ratories, Burlingame, CA). Glasses were mounted on slides
using an anti-fade medium (Vectashield, Vector) and viewed
with a confocal inverted microscope (E2000U; Nikon, Tokyo,
Japan). Images and brightness/contrast levels were captured/
evaluated using the C1 software (Nikon) and the Adobe
Photoshop 7.0 program (Adobe Systems Inc., San Jose, CA),
respectively.
Relative real-time RT-PCR:  Total RNA (1x106 cells) was
extracted in OMNIzol (Euroclone), DNaseI treated (AB1709;
Ambion Inc., Austin, TX), quantified (λ260/λ280 >1.8) and
checked for RNA integrity. Three µg total RNA were reverse
transcripted (Mu-MLV; Finnzyme, Milan, Italy) in a PTC-100
programmable thermocycler (MJ Research, Watertown, MA).
cDNAs (3 µl for target gene and 1 µl for referring gene) were
amplified using the Opticon2 real time termocycler (MJ Re-
search) in a 20 µl final volume of SYBR Green PCR mixture
(Applied Biosystems, Foster City, CA). The temperature pro-
file included initial 95 °C for 15 min incubation, followed by
35-47 cycles of denaturation at 95 °C for 30 s, annealing at
55-60 °C for 25 s (see previous paragraph for specific Ta),
elongation at 72 °C for 30 s, fluorescence monitoring at 60-90
°C, 0.01 °C for 0.3 s, and further incubation at 72 °C for 5
min. PCR amplification primer pairs were received from
Genbank or Primer 3 (MWG Biotech, Ebersberg, Germany),
were as follows: NGF (forward: CTG GCC ACA CTG AGG
TGC AT; reverse: TCC TGC AGG GAC ATT GCT CTC; 120
bp; 53 °C Ta; Genbank BC011123); trkANGFR (forward: CAT
CGT GAA GAG TGG TCT CCG; reverse: GAG AGA GAC
TCC AGA GCG TTG AA; 102 bp; 58 °C Ta; Genbank
M23102); p75NTR (forward: CCT ACG GCT ACT ACC AGG
ATG AG; reverse: TGG CCT CGT CGG AAT ACG; 147 bp;
57 °C Ta; Genbank AF187064); αSMA (forward: GAA GGA
GAT CAC GGC CCT A; reverse: ACA TCT GCT GGA AGG
TGG AC; 125 bp; 60 °C Ta; Genbank BC017554); MMP-9
(forward: CAG TCC ACC CTT GTG CTC TTC C; reverse;
GCC ACC CGA GTG TAA CCA TAG C; 113 bp; 60 °C Ta;
Genbank BC006093) and the referring GAPDH gene (forward:
GAA GGG GTC ATT GAT GGC AAC; reverse: GGG AAG
GTG AAG GTC GGA GTC; 100 bp; 53 °C Ta; Genbank
BC013310). Product specificity was assessed by melting curve
analysis of each sample carried out in duplicate as well as by
gel size-fractioning. Ct values normalized samples showing
good melting curves were used for statistical analysis. Differ-
ences in PCR product expression were evaluated by REST©
software [13].
Proliferation assays:  The effect of increasing NGF con-
centration on VKC-FB proliferation was investigated by count-
ing the cells, after brief enzymatic digestion, using the trypan
blue exclusion test. The expression of the nuclear proliferat-
ing factor ki67, recognizing all the cell cycles except G0 [14],
was investigated on previously fixed monolayers stained with
rabbit antihuman ki67 antibody (1:1000, Santa Cruz) and de-
veloped by fluorescent ABC technique (Vector).
Nerve growth factor ELISA:  To evaluate NGF in the su-
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pernatants of VKC and healthy FBs, we carried out a a two-
site NGF ELISA (sensitivity=0.5 pg/ml) [15]. In brief, 96-
well Maxisorp ELISA plates were precoated with monoclonal
antihuman βNGF antibodies (0.4 µg/ml; MAB256, RαD).
Both standards (0.15 pg/ml to 1 ng/ml βNGF; Alomone, Jerusa-
lem, Israel) and samples (1/4) were incubated at 4 °C for 18 h.
ELISA was developed by using polyclonal biotinylated anti-
human ηNGF antibodies (0.15 µg/ml, 500-P85Bt; Peprotech,
Milan, Italy), HRP-streptavidin (1/300; DY998, RαD) and the
ready-to-use TMB substrate (Zymed, San Francisco, CA).
Optical density (OD) was measured at λ450-550 by a microplate
ELISA reader (Sunrise, Tecan Systems, Inc., San Jose, CA).
The biological activity of FB-derived NGF was tested sepa-
rately by using a standardized PC12 bioassay [16]. Protein
normalization was achieved by a Bio-Rad protein assay, us-
ing BSA equivalent as a standard (Bio-Rad Laboratories, Inc.,
Hercules, CA).
Cell surface ELISA:  To investigate the effect of NGF on
αSMA expression by VKC-FBs, an ELISA was carried out
on monolayers [17]. Briefly, FBs (5x105/0.20 ml) were seeded
on 96-well plates. Once the cells reached confluence, they were
incubated with increasing NGF concentrations. After cultur-
ing, plates were washed in HBSS containing 0.1% CaCl2, PFA
post-fixed, quenched for endogenous peroxidases (0.3% H2O2
in PBS for 15 min), permeabilized in TX-PBS, and dehydrated
with 95% ethanol before the assay. The plates were subse-
quently processed for quantification of αSMA (1/500,
Novocastra), types I and type IV collagen (1/1000; Santa Cruz)
proteins, using monoclonal and polyclonal specific antibod-
ies diluted in TW-PBS. Biotin-conjugated antimouse or
antigoat antibodies and HRP-streptavidin (1/10000 and 1/7000,
respectively; Zymed) specific binding were developed with a
ready-to-use TMB and quantified using an ELISA reader.
Western blot analysis:  Total proteins were extracted by
30 min incubation with cold lysis-buffer (50 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1%
SDS, 7 µg/ml aprotinin, and 1 mM PMSF). Equivalent pro-
tein amounts (40-80 µg; Bio-Rad protein assay) were boiled
for 5 min under reducing conditions and fractionated on a 4%
stacking/6-15% gradient resolving gel at 160 V/60 min
(Miniprotean3 apparatus, Bio-Rad). Electrophoresed proteins
were transferred to Hy-bond membranes using a semi-dry blot-
ting apparatus (12 V/45 min, Bio-Rad). A molecular weight
marker (6-210 kDa; SERVA) was run in parallel. Transferred
proteins (Ponceau S staining) were probed at 4 °C for 18 h
with primary antibodies diluted in TW-PBS (αSMA, types I
and type IV collagen: 0.2 µg/ml; MMP9: 0.4 µg/ml), labeled
with secondary POD-conjugated specific antibodies (1/7000,
90 min; Jackson), and developed by ECL technique
(SuperSignal West Pico Trial; Pierce, Rockford, IL) in a high
performance Kodak imager station (Kodak 550, Eastman
Kodak Company, Scientific Imaging Systems, Rochester, NY).
Bands were digitally captured using the 1D Kodak Image
Analysis Software, subjected to densitometric analysis, and
processed in Adobe Photoshop 7.0. Membranes were stripped
at 56 °C for 45 min in 1 M Tris-HCl containing 2% SDS and
1.25 mM β-mercaptoethanol and reprobed with GAPDH an-
tibodies (0.2 µg/ml; Abcam, Cambridge, UK), to verify equal
protein loading.
SDS-PAGE zymography:  After culturing, the conditioned
media were collected and clarified by centrifugation. MMP
activity was analyzed by zymography, using a procedure de-
scribed in reference [18]. Briefly, 50 µl conditioned media
were mixed with SDS sample buffer, without β-ME, and heated
for 37 °C/30 min. Normalized samples (30 µg/lane; Bio-Rad
protein assay) underwent standardized electrophoresis in 10%
SDS-PAGE containing 0.1% gelatin (Bio-Rad). Molecular
weight markers (6-210 kDa), recombinant human latent MMP9
(92 kDa), and active MMP9 (83 kDa; Calbiochem) were loaded
as positive controls. The gel was washed in 2.5% TX-PBS to
remove SDS and renature the proteins, incubated at 37 °C for
48 h in an activation buffer (50 mM Tris-HCl, 200 mM NaCl,
10 mM CaCl2; pH 7.5), rinsed in ddw, and finally stained for
60 min with 0.25% Coomassie brilliant blue R250 in 40%
isopropanol. Gelatinolytic activity was identified as clear bands
on a uniform blue background following destaining in 7%
acetic acid, indicating the area where gelatin was digested.
Statistics:  All experiments were done three times, with
each point carried out in duplicate. Experimental results are
expressed as mean±SEM. Parametric ANOVA followed by
Tukey-Kramer post hoc was employed to analyze the data [19],
using the statistical package StatView II for PC (Abacus Con-
cepts Inc., Barkley, CA). A probability of less than or equal to
0.05 was considered to be statistically significant.
RESULTS
Vernal keratoconjunctivitis-derived fibroblasts express nerve
growth factor, trkANGFR, p75NTR, and αSMA:  Increased NGF
levels were detected by specific ELISA in the conditioned
media of VKC-FBs and compared to healthy-FBs
(563.33±35.12 pg/ml versus 445.67±10.59 pg/ml; 26.51% in-
crease; p=0.005). This data is in accordance with the NGF
mRNA upregulation observed in VKC-FBs (Figure 1A). RT-
PCR and confocal analysis revealed that VKC-FBs expressed
both trkANGFR and p75NTR. In contrast, healthy FBs only ex-
press trkANGFR, as previously reported [8] (Figure 1A,B). A
slight downregulation of trkAmRNA expression was found in
VKC-FBs, in comparison to healthy ones (p<0.05). As de-
tected by cs-ELISA, a significant increase of αSMA expres-
sion was observed in VKC-FBs (0.378±0.027 OD VKC-FBs
versus 0.232±0.046 OD healthy-FBs; a 1.62-protein increase
[p<0.01]). VKC-FBs expressed αSMA protein in association
with p75NTR (Figure 1C). No proliferation was observed in the
presence of increasing NGF concentrations (data not shown).
Nerve growth factor does not modulate αSMA expression:
VKC-FBs were exposed to increasing NGF concentrations (1-
500 ng/ml) in order to investigate whether NGF was able to
influence αSMA expression. At both cs-ELISA and western
blot analysis, NGF was not able to influence αSMA expres-
sion in VKC-FBs (Figure 2; dark bars [p>0.05]). NGF stimu-
lation did not influence αSMA expression after preincubations
with neutralizing trkANGFR antibodies, (data not shown). In
contrast, preincubation with neutralizing p75NTR antibodies
followed by increasing NGF concentrations resulted in an in-
983crease of αSMA expression (Figure 2; light bars [p<0.05]).
The pattern of αSMA expression resembled those of NGF-
treated healthy FBs [8].
Nerve growth factor modulates types I and IV collagen
expression:  In VKC-FBs, the high amount of αSMA was
found associated with a high rate of types I and IV collagen
(rate; 7.78: type I, 1.323±0.248 and type IV, 0.170±0.004), as
compared to healthy FBs (type I, 0.993±0.001 and type IV,
0.077±0.014; p<0.05; see also Table 1). After NGF exposure,
the expression of type I collagen by VKC-FBs was signifi-
cantly decreased at all the concentration levels tested (Figure
3A). The maximum effect was observed at 10 ng/ml (1.33-
target gene decrease, p<0.05), reaching a level almost compa-
rable to those of healthy-FBs (Figure 3A; light bar). By con-
trast, the expression of type IV collagen was not changed at
any NGF concentration level (Figure 3B; light bars).
Nerve growth factor modulates MMP-9 expression and
function:  The expression and functional activities of MMP9,
known to drive specifically collagen type IV cleavage [20],
was investigated as a function of NGF stimulation in VKC-
FBs. VKC-FBs were exposed to increasing NGF concentra-
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Figure 1. Nerve growth factor, trkANGFR, p75NTR
and αSMA expression by vernal keratoconjunc-
tivitis-derived fibroblasts.  A: Conventional RT-
PCR. showing from left to right, nerve growth
factor (NGF; 120 bp), trkANGFR (103 bp); p75NTR
(100 bp) amplicons. The lines are as follows:
(1) -RT, (2) healthy-FBs, and (3) VKC-FBs.
These are representative gels from three inde-
pendent experiments where equal amounts of
cDNA were amplified. B: Confocal microscopy
on VKC-FBs showing, from left to right, that
VKC-FBs express p75NTR (Cy3, red) and
trkANGFR (Cy2, green). p75NTR and trkANGFR
colocalized in some cellular compartments
(merge; X600/oil immersion). C: Confocal mi-
croscopy on VKC-FBs showing, from left to
right, that these cells express p75NTR (Cy3, red)
and αSMA (Cy2, green). p75NTR and αSMA
colocalized in some cellular compartments
(merge; X600/oil immersion).
Figure 2. αSMA expression by vernal keratoconjunctivitis-derived
fibroblasts.  Increasing NGF concentrations did not influence αSMA
expression by VKC-FBs (dark bar; p>0.05). αp75NTR neutralization
(1 µg/ml/30 min) significantly increased αSMA expression by NGF-
treatment (light bar; p<0.05). αtrkANGFR neutralization did not influ-
ence αSMA expression by NGF treated VKC-FBs (data not shown).
Representative data from three independent experiments, which re-
sults are shown as mean OD±SEM.
984tions (1-100 ng/ml) and the expression of MMP9 protein and
mRNA were evaluated and compared to untreated VKC-FBs.
By western blot analysis, it was determined that NGF signifi-
cantly increased MMP9 protein expression in VKC-FBs, as
compared to healthy-FBs, in a dose-dependent fashion (Fig-
ure 4A). This specific MMP9 increase was associated with an
increase of MMP9 activities, as shown by gelatinolytic bands,
at the same concentrations tested (Figure 4B). In agreement
with biochemical data, the molecular analysis showed that
NGF was able to trigger the MMP9-mRNA expression in a
dose-dependent fashion with the maximum expression at 10
ng/ml NGF (3.92-target gene increase, p<0.05; Figure 4C).
Interestingly, the MMP9-mRNA increasing effect of 10 ng/
ml NGF was found to be comparable to that of 1 ng/ml TGFβ1
(5.48±0.04 versus 7.49±0.09, respectively). According to the
literature, MMP9 mRNA was found to be increased in VKC-
FBs as compared to healthy-FBs (24.98-target gene increase;
p<0.05 [3]). Biochemical and molecular characteristics of
healthy and VKC-derived FBs are summarized in Table 1.
DISCUSSION
 Our data demonstrated that primary cultures of VKC-FBs
express both trkANGFR and p75NTR receptors and produce high
levels of NGF, types I and IV collagens, and MMP9. More-
over, VKC-FBs are mainly represented by myoFBs, since a
consistent proportion of VKC-FBs were αSMA positive.
Various Th2-derived cytokines and growth factors are in-
creased in blood, tears, and conjunctiva from VKC patients.
These profibrotic factors were found able to drive the cross-
talk between structural (epithelium and FBs) and inflamma-
tory (lymphocytes, eosinophils, and mast cells) cells. This cell-
factor interaction contributes to the chronic inflammatory pro-
cess, giant papillae formation and tissue remodeling, as ob-
served in VKC [2,3,5,21-23]. Among these, TGFβ1 isoform
remains the main pro-fibrogenic factor, being responsible for
ECM ex-novo deposition, the inhibition of ECM degradation
and the prolonged myoFB activity [24].
NGF is also increased in VKC blood and conjunctiva as a
result of the activation of both structural (epithelium and FBs)
and inflammatory cells (Th2 lymphocytes, mast cells, and
eosinophils), during the active conjunctivitis [7,22]. Older and
more recent data [8,22-24] indicate that NGF is a pleiotrophic
factor participating to the control of inflammatory responses,
tissue repair, fibrosis, and remodeling in different tissues. Pri-
mary cultures of healthy-FBs have been found to be modu-
lated by NGF with relation to cell migration, differentiation,
and contraction of a cell matrix [8].
Since stromal FBs represent the major target/effector cells
involved in tissue remodeling [6,12,25] and since NGF acti-
vates in vitro healthy-FBs [8,26,27], we sough to evaluate the
possible modulation of FBs isolated from conjunctiva of pa-
tients with VKC by NGF, hence no data are available in litera-
ture.
©2007 Molecular Vision Molecular Vision 2007; 13:981-7 <http://www.molvis.org/molvis/v13/a104/>
Figure 3. Nerve growth factor modulates type I and type IV collagen
expression.  VKC-FBs showed high types I and IV collagen produc-
tion in comparison to healthy-FBs (rate: 7.78; p<0.05). Increasing
NGF concentrations significantly decreased type I collagen expres-
sion (A), with a maximum at 10 ng/ml NGF (1.33 fold decrease;
p<0.05). No effect was observed on type IV collagen expression (B).
Representative data from three independent experiments are shown
as mean OD±SEM.
TABLE 1. BIOCHEMICAL AND MOLECULAR DESCRIPTION OF HEALTHY AND VERNAL KERATOCONJUNCTIVITIS-DERIVED FIBROBLASTS
Biochemical and molecular description of healthy and vernal keratoconjunctivitis-derived fibroblasts
985In the present study, increased expression of NGF, asso-
ciated with increased expression of p75NTR and αSMA, was
detected in VKC-FBs as compared with conjunctival healthy-
FBs. In addition, αSMA was found expressed in FBs showing
light upregulation of trkANGFR and considerable upregulation
of p75NTR, suggesting a specific role for NGF in VKC-FBs. In
line with the effect of NGF in driving the differentiation of
healthy FBs into myoFBs [8], we wondered whether NGF
supplementation to VKC-FBs cultures would result in a fur-
ther VKC-FB differentiation, evaluated as αSMA expression.
Interestingly, NGF failed to further increase αSMA expres-
sion in VKC-FBs, unless p75NTR was blocked (see Figure 2;
light bars). This data is of great interest, since it suggests two
possible hypothesis: (1) NGF plays a differentiating effect
through the specific and unique binding to trkANGFR (NGF is a
specific receptor), but not p75NTR (the pan-neurotrophin re-
ceptor); and (2) the specific expression of p75NTR, by myoFB
phenotype (otherwise absent in FBs), seems to play a switch-
off effect in the further differentiating action of NGF, suggest-
ing that NGF plays a modulatory rather than a exclusive stimu-
latory effect on the fibrotic process. The answer might lie in
trkANGFR/p75NTR multifaceted functions [7,22].
On the other side in VKC tissue remodeling process, NGF
might modulate collagen production and might influence
MMP2/MMP9 production/activity, as previously demonstrated
for other growth factors [2,4]. ECM metabolism is heavily
impaired in VKC, due to a substantial increase in total col-
lagen deposition in the conjunctiva (mainly types I, III, and
IV), and an increased release of MMP2/MMP9 in the tears
[3,4]. In this study, the expression of type-I collagen decreased
significantly after NGF exposure, rather quite specific given
that this effect was not observed for type-IV collagen or with
the addition of TGFβ1 (data not shown). In addition, NGF
was able to induce specifically MMP9 expression/activity by
VKC-FBs at both molecular, biochemical and functional lev-
els. This effect was not observed in healthy-FBs, as previ-
ously reported [8].
Taken together, these data suggest a many-sided role of
NGF in VKC tissue remodeling. NGF is increased in VKC
blood and tarsal conjunctiva and likewise in tears [9]. In in
vitro studies, NGF induces the differentiation of healthy con-
junctival FBs into myoFBs, the main effector and target cells
of fibrotic process. This differentiating effect was not observed
in VKC-derived conjunctival FBs in the present study. Addi-
tionally, NGF induced a decrease in type I collagen and an
increase in MMP9 expression by VKC-FBs with no specific
effect on both MMP1 and MMP2 mRNA expression. It has
been previously reported that both MMP2 and MMP9 degrade
types IV and V collagen; MMP9 can also degrade types I and
type III collagen [28,29]. One possible explanation for these
data might be related to the well-known singular action of
NGF due to changes in the balance between trkANGFR/p75NTR
expression. In this study we demonstrated a role of trkANGFR
in the differentiating effect of NGF on FBs; however, the role
of p75NTR on VKC-FB function seems complex and remains
to be elucidated.
In VKC, various growth factors and Th2-cytokines are
produced by inflammatory/stromal cells. In line with other
studies, these factors have been proposed to modulate tissue
remodeling in VKC. To summarize, our in vitro findings show-
ing the NGF modulation of both type I collagen and MMP9,
might propose NGF as an active contributor in VKC remodel-
ing.
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Figure 4. Nerve growth factor increases MMP9 expression and func-
tion by vernal keratoconjunctivitis-derived fibroblasts.  Conditioned
media were collected and processed as described in Methods. A: The
histogram shows a significant increase of MMP9 protein expression
in VKC-FBs treated with increasing NGF concentrations, according
to the densitometric analysis (mean OD±SEM; p<0.05). Data were
normalized to GAPDH expression and presented as fold increase with
respect to untreated VKC-FBs. B: The functional activity in MMP9
was investigated by SDS-PAGE zymography. From left to right (1-6
lines): 0, 1, 10, 100, 250, 500 ng/ml NGF; line 7, αNGF+100 ng/ml
NGF. Panel represents one of three independent gels that gave the
same results. C: Relative real-time PCR showed a significant increase
of MMP9 mRNA expression in VKC-FBs treated with different con-
centrations of NGF (p<0.05). Data were normalized to
GAPDHmRNA expression and presented as fold increase [11] with
respect to untreated VKC-FBs.
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